Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00477815
Status:
COMPLETED
Last Update Posted:
2018-05-14
First Post:
2007-05-23
Brief Title:
Rituximab Yttrium Y 90 Ibritumomab Tiuxetan Melphalan and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Organization Data
Organization:
Mayo Clinic
Class:
OTHER
Study ID:
CDR0000546732
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mayo Clinic
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |